Myrbetriq: Medgend

Myrbetriq FDA Approved Drugs

MYRBETRIQ [Mirabegron^{C₂₁H₂₄N₄O₂S}]

25mg (oral tablet, extended release)

50mg (oral tablet, extended release)

Apgdi^{Jun 28, 2012}

For the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.